CareMax Net Worth

CareMax Net Worth Breakdown

  CMAX
The net worth of CareMax is the difference between its total assets and liabilities. CareMax's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of CareMax's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. CareMax's net worth can be used as a measure of its financial health and stability which can help investors to decide if CareMax is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in CareMax stock.

CareMax Net Worth Analysis

CareMax's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including CareMax's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of CareMax's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform CareMax's net worth analysis. One common approach is to calculate CareMax's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares CareMax's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing CareMax's net worth. This approach calculates the present value of CareMax's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of CareMax's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate CareMax's net worth. This involves comparing CareMax's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into CareMax's net worth relative to its peers.

Enterprise Value

378.32 Million

To determine if CareMax is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding CareMax's net worth research are outlined below:
CareMax generated a negative expected return over the last 90 days
CareMax has high historical volatility and very poor performance
CareMax has some characteristics of a very speculative penny stock
CareMax has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 751.1 M. Net Loss for the year was (683.35 M) with profit before overhead, payroll, taxes, and interest of 80.3 M.
CareMax currently holds about 68.13 M in cash with (46.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
CareMax has a frail financial position based on the latest SEC disclosures
Roughly 24.0% of the company shares are held by company insiders
Latest headline from benzinga.com: Gold Down Over 3 Rigetti Computing Shares Spike Higher

CareMax Quarterly Good Will

156.84 Million

CareMax uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in CareMax. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CareMax's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
14th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know CareMax's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as CareMax is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CareMax backward and forwards among themselves. CareMax's institutional investor refers to the entity that pools money to purchase CareMax's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Tower Research Capital Llc2024-09-30
5.1 K
Bank Of America Corp2024-09-30
K
Barclays Plc2024-09-30
789
Royal Bank Of Canada2024-09-30
500
Fortitude Family Office Llc2024-09-30
187
Bnp Paribas Arbitrage, Sa2024-09-30
182
Cwm, Llc Duplicate2024-06-30
77.0
Jpmorgan Chase & Co2024-09-30
54.0
Citigroup Inc2024-09-30
34.0
Deerfield Management Co2024-09-30
530.2 K
Morgan Stanley - Brokerage Accounts2024-09-30
353.5 K
Note, although CareMax's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow CareMax's market capitalization trends

The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.91 M.

Market Cap

60.89 Million

Project CareMax's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(1.87)(1.78)
Return On Capital Employed(3.56)(3.38)
Return On Assets(1.10)(1.04)
Return On Equity(11.12)(10.57)
The company has Profit Margin (PM) of (1.0) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.1) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.1.
When accessing CareMax's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures CareMax's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of CareMax's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in CareMax's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CareMax. Check CareMax's Beneish M Score to see the likelihood of CareMax's management manipulating its earnings.

Evaluate CareMax's management efficiency

CareMax has return on total asset (ROA) of (0.1059) % which means that it has lost $0.1059 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.2842) %, meaning that it created substantial loss on money invested by shareholders. CareMax's management efficiency ratios could be used to measure how well CareMax manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -1.78 in 2024. Return On Capital Employed is likely to rise to -3.38 in 2024. At this time, CareMax's Other Current Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 26 M in 2024, despite the fact that Net Tangible Assets are likely to grow to (175 M).
Last ReportedProjected for Next Year
Book Value Per Share 16.48  15.66 
Tangible Book Value Per Share(52.75)(55.38)
Enterprise Value Over EBITDA(0.82)(0.78)
Price Book Value Ratio 0.91  0.86 
Enterprise Value Multiple(0.82)(0.78)
Price Fair Value 0.91  0.86 
Enterprise Value433.9 M378.3 M
Evaluating the management effectiveness of CareMax allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The CareMax Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue
0.6337
Revenue
784.6 M
Quarterly Revenue Growth
(0.12)
Revenue Per Share
208.339
Return On Equity
(3.28)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CareMax insiders, such as employees or executives, is commonly permitted as long as it does not rely on CareMax's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CareMax insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
CareMax time-series forecasting models is one of many CareMax's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CareMax's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

CareMax Earnings per Share Projection vs Actual

CareMax Corporate Management

Carlos SoloPresident, CoFounderProfile
Samantha SwerdlinVice RelationsProfile
Niberto MDChief OfficerProfile
Nicole CableChief OfficerProfile
Teresa McMeansChief OfficerProfile
Erick CPAChief OfficerProfile

Additional Tools for CareMax Stock Analysis

When running CareMax's price analysis, check to measure CareMax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CareMax is operating at the current time. Most of CareMax's value examination focuses on studying past and present price action to predict the probability of CareMax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CareMax's price. Additionally, you may evaluate how the addition of CareMax to your portfolios can decrease your overall portfolio volatility.